iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc.（ITOS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
itos · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2025年10月17日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Hold
8 位分析师
共识
评级分布
12 个月目标价
High
$46.00
Consensus
$18.20
+79.3% upside
Low
$9.00
Median: $12 · Last Close: $10.15
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$18.20
79.3% upside
High Target
$46
353.2%
Low Target
$9
-11.3%
Current Price
$10.15
as of today
Based on analyst price targets, the ITOS stock price prediction for the next 12 months ranges from $9 to $46. The consensus ITOS price forecast of $18.20 implies 79.3% upside from the current price of $10.15.
短期股价预测
Ranging算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $10.14 | ↓ 0.06% |
1-day model range: $10.14–$10.15. Peak: $10.15 (-0.06%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -50.0% |
| 2028 | $4 | -63.7% |
| 2029 | $3 | -69.2% |
| 2030 | $3 | -71.8% |
| 2031 | — | -73.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ITOS · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-08-07 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-05-28 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2025-05-28 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2025-05-14 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-05-14 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2025-05-14 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-05-14 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-05-13 | JP Morgan | Downgrade ↓ | Overweight→Neutral |
| 2025-04-29 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-03-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on iTeos Therapeutics, Inc. (ITOS) stock. Of the recent 40 rating actions, 0 were upgrades and 5 were downgrades. 8 analysts currently cover ITOS.
分析师推荐趋势
ITOS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$-8M
↓ 110.5% YoY
Revenue Next Year
$7M
↓ 183.8% YoY
EPS This Year
$-3.72
EPS Next Year
$-2.00
↓ 46.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast ITOS EPS of $-3.72 for the current fiscal year, based on estimates from 2 analysts. The ITOS revenue forecast is $-8M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ITOS 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ITOS 的共识目标价为 $18.20（+79.3% 上行空间），分析师共识为 Hold。
ITOS 的短期预测（明日）为 $10.14（-0.06%）。 ITOS 对 2027 年的股价预测均值为 $5。 ITOS 对 2030 年的预测区间为 $3–$3。
iTeos Therapeutics, Inc. 在 NASDAQ 上市，代码 ITOS。ITOS 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 38% 对应 Hold 共识。
常见问题
ITOS 预测 · 8 个问题根据 8 位华尔街分析师，ITOS 的 12 个月平均目标价为 $18.20，最高 $46.00、最低 $9.00。若有图表，中位目标价可在上方查看。相对当前价 $10.15，隐含约 +79.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.